You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

autologous vaccination

Showing 1 - 25 of 7,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

Completed
Has Results
  • Breast Cancer
  • Autologous, Lethally Irradiated Breast Cancer Cells
  • Boston, Massachusetts
  • +1 more
Mar 30, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

    Not yet recruiting
    • COVID-19
    • +2 more
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Oct 27, 2022

      Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Ovarian Carcinoma
      • XP-DC vaccinations
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Mar 6, 2023

      Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

      Completed
      Has Results
      • Breast Cancer
      • Autologous, Lethally Irradiated Breast Cancer Cells
      • Boston, Massachusetts
      • +1 more
      Mar 30, 2022

      Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

      Active, not recruiting
      • Giant Cell Glioblastoma
      • +2 more
      • Laboratory Biomarker Analysis
      • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
      • Rochester, Minnesota
        Mayo Clinic
      Jan 4, 2023

      Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

      Completed
      • Multiple Myeloma
      • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
      • Standard of care
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 22, 2022

      Melanoma Trial in Boston (Autologous, lethally irradiated melanoma cells)

      Active, not recruiting
      • Melanoma
      • Autologous, lethally irradiated melanoma cells
      • Boston, Massachusetts
      • +1 more
      Feb 2, 2022

      Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

      Terminated
      Has Results
      • Prostatic Neoplasms
      • Prostate Cancer
      • Autologus elutriated monocyte placebo vaccine
      • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Mar 10, 2022

      Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

      Active, not recruiting
      • Melanoma, Uveal Metastatic
      • Vaccination with IKKb matured Dendritic Cells
      • Erlangen, Bavaria, Germany
        University Hospital Erlangen Dept. of Dermatology
      Mar 16, 2022

      Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

      Completed
      • Prostate Cancer
      • Intratumoral (IT) Poly ICLC 0.5 mg
      • +3 more
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Sep 8, 2022

      Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)

      Active, not recruiting
      • Uveal Melanoma
      • Autologous Dendritic Cells loaded with autologous Tumor RNA
      • Erlangen, Bayern, Germany
      • +7 more
      Nov 29, 2022

      GBM Trial in Taichung, Taoyuan (autologous dendritic cells)

      Recruiting
      • GBM
      • autologous dendritic cells
      • Taichung, Non-US, Taiwan
      • +2 more
      Mar 21, 2022

      NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Dendritic cell immunotherapy
      • +2 more
      • Ghent, Belgium
        Ghent University Hospital
      Dec 23, 2022

      Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

      Terminated
      Has Results
      • Myelodysplastic Syndrome
      • +2 more
      • GVAX
      • +6 more
      • Boston, Massachusetts
      • +3 more
      Jun 30, 2022

      Glioblastoma, Vaccination Trial in Meldola (Autologous Dendritic Cells (DC) vaccine, Temozolomide)

      Not yet recruiting
      • Glioblastoma
      • Vaccination
      • Meldola, FC, Italy
        Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
      Feb 25, 2021

      Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

      Completed
      • Glioblastoma
      • +4 more
      • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
      • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Nov 18, 2021

      Myeloid Leukemia, Chronic Trial in Berlin, Bremen (DC vaccine)

      Recruiting
      • Myeloid Leukemia, Chronic
      • DC vaccine
      • Berlin, Germany
      • +1 more
      Aug 3, 2021

      Multiple Myeloma Trial in United States (procedure, drug, biological)

      Completed
      Has Results
      • Multiple Myeloma
      • Tumor Cell Collection
      • +6 more
      • San Francisco, California
      • +14 more
      Jul 11, 2022

      Malignant Melanoma of Skin Stage III, Malignant Melanoma of Skin Stage IV Trial in Meldola (arm 1: DC Vaccine + RT, arm 2: DC

      Recruiting
      • Malignant Melanoma of Skin Stage III
      • Malignant Melanoma of Skin Stage IV
      • arm 1: DC Vaccine + RT
      • +3 more
      • Meldola, FC, Italy
        UO Immunoterapia e laboratorio TCS, IRST IRCCS
      Feb 25, 2021

      Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)

      Active, not recruiting
      • Giant Cell Glioblastoma
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      Nov 3, 2021

      Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

      Recruiting
      • Recurrent Glioblastoma
      • Dendritic Cell Tumor Cell Lysate Vaccine
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Mar 29, 2022

      NSCLC Metastatic Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

      Active, not recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Dendritic cell immunotherapy
      • +2 more
      • Ghent, Belgium
        Ghent University Hospital
      Mar 29, 2021

      Melanoma, Head Neck Cancer, Sarcoma Trial in United States (Hiltonol)

      Completed
      • Melanoma
      • +3 more
      • Hiltonol
      • Chevy Chase, Maryland
      • +4 more
      Dec 15, 2020